ASTROGEN CO LTD has a total of 13 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets foods and drinks, pharmaceuticals and organic fine chemistry are MCPHARMA BIOTECH INC, KALMARNA LTD and QUEGEN BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | Israel | 1 | |
#6 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Foods and drinks | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Special foods | |
#3 | Foods | |
#4 | Therapeutic chemical compounds | |
#5 | Fodder | |
#6 | Special acyclic compounds | |
#7 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Jun Do Youn | 10 |
#2 | Kim Young Ho | 8 |
#3 | Lee Min Yong | 7 |
#4 | Jo Young Kyoung | 7 |
#5 | Kim Min Joo | 7 |
#6 | Whang Su-Kyeong | 5 |
#7 | Seo Min Sook | 5 |
#8 | Hwang Su Kyeong | 3 |
#9 | Su Kyeong Hwang | 2 |
#10 | Young Ho Kim | 2 |
Publication | Filing date | Title |
---|---|---|
KR20200120266A | Pharmaceutical composition comprising the magnesium-serinate as an effective component for prevention or treatment of diabetes and health functional food comprising the same | |
KR20200119169A | Protectant against neuronal cell death by oxidative stress comprising l-serine and the root extract of angelica gigas as an effective component | |
KR102022118B1 | Serine derivative compound for the prevention or treatment of centralnervous system diseases | |
KR101952443B1 | Novel magnesium-serinate compound and use thereof | |
KR20180101242A | L-serine compositions for preventing, improving or treating neurodevelopmental disorders |